Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate
American Journal of Cardiology - United States
doi 10.1016/0002-9149(87)90219-0
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 1987
Authors
Publisher
Elsevier BV